{"SPADE_N_14035": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14035", "Peptide Name": "HH973 (synthetic AMPs, Trp-rich; XXA, UCLL1c)", "Source": "Amino acid substitution of indolicidin, bovine cathelicidin analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FIKWKFRWWKWR", "Sequence Length": 12, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1867.25, "PI": 12.0, "Hydrophobicity": -1.18, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Hancock RE, Hilpert K, Cherkasov A, Fjell C.2006", "Reference": "Patent US9017656", "Title": "SMALL CATIONIC ANTIMICROBIAL peptides"}], "Frequent Amino Acids": "WKF", "Absent Amino Acids": "ACDEGHLMNOPQSTUVY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 5, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (64.29%) toIndolicidin analog HH972W: 33%.Activity: active against P. aeruginosa PAO1 (MIC 8 ug/ml), E. coli (MIC 4 ug/ml), S. typhimurium (MIC 8 ug/ml), S. aureus (MIC 4 ug/ml), S. epidermidis (MIC 2 ug/ml), E. faecalis ATCC29212 (MIC 8 ug/ml), and C. albicans (MIC 8 ug/ml). It is the most active one in this indolicidin variants.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_05667", "Similarity": 1.0, "Sequence": "FIKWKFRWWKWRK"}, {"SPADE_ID": "SPADE_UN_15414", "Similarity": 1.0, "Sequence": "IKWKRWWWR"}, {"SPADE_ID": "SPADE_UN_00358", "Similarity": 1.0, "Sequence": "KWKWKW"}]}}}